1. COSMIC, chemotherapy plus ofatumumab at standard or mega‐dose in chronic lymphocytic leukaemia, a phase II randomised study. (24th May 2021) Authors: Allsup, David; Howard, Dena; Emmerson, Jake; Hockaday, Anna; Rawstron, Andy; Oughton, Jamie B.; Bloor, Adrian; Phillips, David; Nathwani, Amit; Paneesha, Shankara; Turner, Deborah; Munir, Talha; Hillmen, Peter Journal: British journal of haematology Issue: Volume 194:Number 3(2021) Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Expression patterns of CD180 in the lymph nodes of patients with chronic lymphocytic leukaemia. (5th July 2021) Authors: Edwards, Kurtis; Zaitseva, Kristina; Sayed, Uzma; Volpi, Emanuela V.; Nathwani, Amit; Gribben, John G.; Lydyard, Peter; Krysov, Sergey; Porakishvili, Nino Journal: British journal of haematology Issue: Volume 195:Number 2(2021) Page Start: e131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Human induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co‐express gamma and beta globins. (16th May 2014) Authors: Yang, Cheng‐Tao; French, Anna; Goh, Pollyanna Agnes; Pagnamenta, Alistair; Mettananda, Sachith; Taylor, Jenny; Knight, Sam; Nathwani, Amit; Roberts, David J.; Watt, Suzanne M.; Carpenter, Lee Journal: British journal of haematology Issue: Volume 166:Number 3(2014:Aug.) Page Start: 435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Potential limits of AAV‐based gene therapy with the use of new transgenes expressing factor IX fusion proteins. Issue 1 (6th December 2018) Authors: Le Quellec, Sandra; Dane, Allison; Enjolras, Nathalie; McIntosh, Jenny; Rosales, Cecilia; Negrier, Claude; Nathwani, Amit Journal: Haemophilia Issue: Volume 25:Issue 1(2019) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Preclinical development of novel humanised ROR1 targeting chimeric antigen receptor T cells and bispecific T-cell engagers. (23rd February 2017) Authors: Gohil, Satyen; Paredes-Moscosso, Solange; Harrasser, Micaela; Davidoff, Andrew; Pule, Martin; Della Peruta, Marco; Nathwani, Amit Journal: Lancet Issue: Volume 389(2017)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗